Reported 1 day ago
This article examines the investment potential of two rapidly rising stocks, Kopin (KOPN) and Nephros (NEPH), both trading under $10. While Kopin, specializing in microdisplay technologies for defense, shows significant stock movement but concerns regarding revenue consistency, Nephros, which focuses on water filtration for healthcare, demonstrates stronger growth and profitability. The conclusion leans towards Nephros as the more viable long-term investment compared to Kopin.
Source: YAHOO